To check the clinical significance of CBP and GCN5 expression in BC patients, we investigated the clinical characteristics of the patients and histopathological parameters of the tumors of our BC patient cohort, e.g., age at diagnosis, tumor type and its histological grade, lymph node status and the TNM stage of breast carcinomas as well as the survival of the patients. This evidence concerns the gene KAT2A and breast carcinoma.